announces

NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports

NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

11 months ago

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

BELLEVUE, Wash. and ZUG, Switzerland, July 9, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing…

11 months ago

LQWD Announces Upsized Financing with Amended Terms of Up to C$12.3 Million

July 08, 2025 23:58 ET  | Source: LQWD Technologies Corp. THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE…

11 months ago

Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

July 08, 2025 21:36 ET  | Source: Cogent Biosciences, Inc. WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE)…

11 months ago

Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science

A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted metabolomics partner in the life sciences industry MORRISVILLE,…

11 months ago

NYSE Content advisory: Pre-Market update + Trump announces new tariffs on 14 countries

NEW YORK, July 8, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

11 months ago

Veeda Lifesciences announces partnership with Mango Sciences to bring AI innovation in clinical trials services

AHMEDABAD, India, July 8, 2025 /PRNewswire/ -- Veeda Lifesciences, a global contract research organization (CRO), has announced an investment in…

11 months ago

AB Science announces the successful completion of a EUR 1.925 million private placement

PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENT Paris, July 8, 2025, 8am…

11 months ago

Diginex Announces Plans for Eight-for-One Forward Stock Split

July 07, 2025 23:29 ET  | Source: Diginex Limited LONDON, July 07, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or…

11 months ago

UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and…

11 months ago